139 related articles for article (PubMed ID: 11525808)
21. Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.
Buchwald B; Weishaupt A; Toyka KV; Dudel J
Neurosci Lett; 1995 Dec; 201(2):163-6. PubMed ID: 8848243
[TBL] [Abstract][Full Text] [Related]
22. [A case of multifocal motor neuropathy with IgM lambda anti-GM1 antibody and IgM kappa paraprotein reacting exclusively with GM2].
Arai M; Kusunoki S
Rinsho Shinkeigaku; 2009; 49(2-3):123-6. PubMed ID: 19348179
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathy.
Brindel I; Preud'homme JL; Vallat JM; Vincent D; Vasquez JL; Jauberteau MO
Neurosci Lett; 1994 Nov; 181(1-2):103-6. PubMed ID: 7534889
[TBL] [Abstract][Full Text] [Related]
24. Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease.
Schluep M; Steck AJ
Neurology; 1988 Dec; 38(12):1890-2. PubMed ID: 2461538
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal IgM cold agglutinins with anti-Pr1d specificity in a patient with peripheral neuropathy.
Herron B; Willison HJ; Veitch J; Roelcke D; Illis LS; Boulton FE
Vox Sang; 1994; 67(1):58-63. PubMed ID: 7975454
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc).
Sanai Y; Yamasaki M; Nagai Y
Biochim Biophys Acta; 1988 Feb; 958(3):368-74. PubMed ID: 2449247
[TBL] [Abstract][Full Text] [Related]
27. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
[TBL] [Abstract][Full Text] [Related]
28. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
29. Sensorimotor demyelinating neuropathy with IgM antibody against gangliosides GD1a, GT1b and GM3.
Mizutani K; Oka N; Kusunoki S; Kaji R; Mezaki T; Akiguchi I; Shibasaki H
J Neurol Sci; 2001 Jul; 188(1-2):9-11. PubMed ID: 11489278
[TBL] [Abstract][Full Text] [Related]
30. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to glycoconjugates in human motor neuron disease.
Latov N; Hays AP; Yu RK; Ito H; Thomas FP
Neurochem Pathol; 1988 Jun; 8(3):181-7. PubMed ID: 3253621
[TBL] [Abstract][Full Text] [Related]
32. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2).
Young WW; MacDonald EM; Nowinski RC; Hakomori SI
J Exp Med; 1979 Oct; 150(4):1008-19. PubMed ID: 512581
[TBL] [Abstract][Full Text] [Related]
33. Reactivity of a human monoclonal anti-GM1 and anti-GD1b IgM antibody with human neurons in cultures.
Jauberteau MO; Brindel I; Baumann N; Preud'homme JL
J Neuroimmunol; 1993 Oct; 48(1):53-7. PubMed ID: 8227308
[TBL] [Abstract][Full Text] [Related]
34. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H
J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091
[TBL] [Abstract][Full Text] [Related]
35. Effect of anti-GM2 antibodies on rat sciatic nerve: electrophysiological and morphological study.
Ortiz N; Sabaté MM; Garcia N; Santafe MM; Lanuza MA; Tomàs M; Tomàs J
J Neuroimmunol; 2009 Mar; 208(1-2):61-9. PubMed ID: 19232749
[TBL] [Abstract][Full Text] [Related]
36. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
[TBL] [Abstract][Full Text] [Related]
37. Differential blocking effects of the monoclonal anti-GQ1b IgM antibody and alpha-latrotoxin in the absence of complement at the mouse neuromuscular junction.
Buchwald B; Ahangari R; Toyka KV
Neurosci Lett; 2002 Dec; 334(1):25-8. PubMed ID: 12431767
[TBL] [Abstract][Full Text] [Related]
38. Human monoclonal IgM with autoantibody activity against two gangliosides (GM1 and GD1b) in a patient with motor neuron syndrome.
Jauberteau MO; Gualde N; Preud'Homme JL; Rigaud M; Gil R; Vallat JM; Baumann N
Clin Exp Immunol; 1990 May; 80(2):186-91. PubMed ID: 2357844
[TBL] [Abstract][Full Text] [Related]
39. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
40. Human monoclonal IgM anti-Gal(beta 1-3)GalNAc autoantibodies bind to the surface of bovine spinal motoneurons.
Thomas FP; Thomas JE; Sadiq SA; van den Berg LH; Roelofs RI; Latov N; Hays AP
J Neuropathol Exp Neurol; 1990 Mar; 49(2):89-95. PubMed ID: 1689771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
